Total buying$00 buys
RVMD
Revolution Medicines, Inc.
NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$4.13M13 sells
Net open-market−$4.13MBuying minus selling
Active insiders4Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 01, 2026
Open-market transaction mix · 13 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 13 | 0 | $0 | $4.13M | -$4.13M |
| Oct 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (4)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- AM-$2.0M
- SB-$922.3k
- MA-$638.4k
- CJ-$158.6k
RVMD transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | S · sale10b5-1 detectedSEC filing ↗ | -$61.6kView disclosure → | |
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | S · sale10b5-1 detectedSEC filing ↗ | -$244kView disclosure → | |
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | S · sale10b5-1 detectedSEC filing ↗ | -$202kView disclosure → | |
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | S · sale10b5-1 detectedSEC filing ↗ | -$324kView disclosure → | |
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | S · sale10b5-1 detectedSEC filing ↗ | -$441kView disclosure → | |
RVMDRevolution Medicines, Inc. | Sandler Alan B.CDO | M · exercise10b5-1 detectedSEC filing ↗ | $353kView disclosure → | |
RVMDRevolution Medicines, Inc. | Cislini JeffSVP · GC | S · sale10b5-1 detectedSEC filing ↗ | -$158kView disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | S · sale10b5-1 detectedSEC filing ↗ | -$625kView disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | M · exercise10b5-1 detectedSEC filing ↗ | $104kView disclosure → | |
RVMDRevolution Medicines, Inc. | Mancini AnthonySR | S · sale10b5-1 detectedSEC filing ↗ | -$117kView disclosure → | |
RVMDRevolution Medicines, Inc. | Anderson Elizabeth MDIR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
RVMDRevolution Medicines, Inc. | Anderson Elizabeth MDIR | S · sale10b5-1 detectedSEC filing ↗ | -$19.5kView disclosure → | |
RVMDRevolution Medicines, Inc. | Anderson Elizabeth MDIR | S · sale10b5-1 detectedSEC filing ↗ | -$291kView disclosure → | |
RVMDRevolution Medicines, Inc. | Anderson Elizabeth MDIR | S · sale10b5-1 detectedSEC filing ↗ | -$512kView disclosure → | |
RVMDRevolution Medicines, Inc. | Anderson Elizabeth MDIR | S · sale10b5-1 detectedSEC filing ↗ | -$959kView disclosure → | |
RVMDRevolution Medicines, Inc. | Anderson Elizabeth MDIR | S · sale10b5-1 detectedSEC filing ↗ | -$174kView disclosure → | |
RVMDRevolution Medicines, Inc. | Anderson Elizabeth MDIR | M · exercise10b5-1 detectedSEC filing ↗ | $5.67kView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period19transactionstxns
- S · Open-market sells · dominant13 · 68%
- M · Option exercise6 · 32%
Activity by reported role
A joint filing can contribute to multiple rolesCDO7
Director7
SR4
GC1
SVP1
Reported Holdings After
Separated by insider, security, and ownership type
Anderson Elizabeth MCommon Stock · Direct
4,333Sep 22, 2026
Sandler Alan B.Common Stock · Direct
52,559Sep 29, 2026
Mancini AnthonyCommon Stock · Direct
39,765Sep 25, 2026
Anderson Elizabeth MStock Option (Right to Buy) · Direct
1,095Sep 22, 2026
Mancini AnthonyStock Option (Right to Buy) · Direct
93,625Sep 25, 2026
Cislini JeffCommon Stock · Direct
51,776Sep 25, 2026
Sandler Alan B.Stock Option (Right to Buy) · Direct
161,300Sep 29, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
Revolution Medicines, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Revolution Medicines, Inc.?
Sandler Alan B., Cislini Jeff, Mancini Anthony, ANDERSON ELIZABETH M.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Sandler Alan B. reported a sale on Sep 29, 2026 valued at $61.6k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $4,135,195.33. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.